Copyright Reports & Markets. All rights reserved.

Global Biological API Drug Manufacturing Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Buy now

Table of Contents

    1 Market Overview

    • 1.1 Biological API Drug Manufacturing Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 In-House manufacturing
      • 1.2.2 Contract manufacturing
    • 1.3 Market Analysis by Applications
      • 1.3.1 Monoclonal Antibody (mAb) Therapies
      • 1.3.2 Vaccines
      • 1.3.3 Insulin Therapies
      • 1.3.4 Interferon Therapies
      • 1.3.5 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Lonza
      • 2.1.1 Business Overview
      • 2.1.2 Biological API Drug Manufacturing Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Lonza Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 AbbVie
      • 2.2.1 Business Overview
      • 2.2.2 Biological API Drug Manufacturing Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 AbbVie Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 DSM
      • 2.3.1 Business Overview
      • 2.3.2 Biological API Drug Manufacturing Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 DSM Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Boehringer Ingelheim BioXcellence
      • 2.4.1 Business Overview
      • 2.4.2 Biological API Drug Manufacturing Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Cytovance Biologics
      • 2.5.1 Business Overview
      • 2.5.2 Biological API Drug Manufacturing Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Cytovance Biologics Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Celltrion
      • 2.6.1 Business Overview
      • 2.6.2 Biological API Drug Manufacturing Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Celltrion Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 CEPiA Sanofi
      • 2.7.1 Business Overview
      • 2.7.2 Biological API Drug Manufacturing Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 CEPiA Sanofi Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Fujifilm Diosynth Biotechnologies
      • 2.8.1 Business Overview
      • 2.8.2 Biological API Drug Manufacturing Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Samsung BioLogics
      • 2.9.1 Business Overview
      • 2.9.2 Biological API Drug Manufacturing Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Samsung BioLogics Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Baxter
      • 2.10.1 Business Overview
      • 2.10.2 Biological API Drug Manufacturing Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Baxter Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Wuxi Biologics
      • 2.11.1 Business Overview
      • 2.11.2 Biological API Drug Manufacturing Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Wuxi Biologics Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 GSK
      • 2.12.1 Business Overview
      • 2.12.2 Biological API Drug Manufacturing Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 GSK Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Vetter
      • 2.13.1 Business Overview
      • 2.13.2 Biological API Drug Manufacturing Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Vetter Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Pfizer CentreOne
      • 2.14.1 Business Overview
      • 2.14.2 Biological API Drug Manufacturing Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Pfizer CentreOne Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Sandoz
      • 2.15.1 Business Overview
      • 2.15.2 Biological API Drug Manufacturing Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Sandoz Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Biological API Drug Manufacturing Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Biological API Drug Manufacturing Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Biological API Drug Manufacturing Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Biological API Drug Manufacturing Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Biological API Drug Manufacturing Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Biological API Drug Manufacturing Market Analysis by Regions

    • 4.1 Global Biological API Drug Manufacturing Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Biological API Drug Manufacturing Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Biological API Drug Manufacturing Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 4.3 Europe Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 4.5 South America Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)

    5 North America Biological API Drug Manufacturing by Country

    • 5.1 North America Biological API Drug Manufacturing Sales, Revenue and Market Share by Country
      • 5.1.1 North America Biological API Drug Manufacturing Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Biological API Drug Manufacturing Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 5.3 Canada Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)

    6 Europe Biological API Drug Manufacturing by Country

    • 6.1 Europe Biological API Drug Manufacturing Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Biological API Drug Manufacturing Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Biological API Drug Manufacturing Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 6.3 UK Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 6.4 France Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 6.5 Russia Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 6.6 Italy Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Biological API Drug Manufacturing by Country

    • 7.1 Asia-Pacific Biological API Drug Manufacturing Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Biological API Drug Manufacturing Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Biological API Drug Manufacturing Revenue and Market Share by Country (2014-2019)
    • 7.2 China Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 7.3 Japan Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 7.4 Korea Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 7.5 India Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)

    8 South America Biological API Drug Manufacturing by Country

    • 8.1 South America Biological API Drug Manufacturing Sales, Revenue and Market Share by Country
      • 8.1.1 South America Biological API Drug Manufacturing Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Biological API Drug Manufacturing Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Biological API Drug Manufacturing by Countries

    • 9.1 Middle East and Africa Biological API Drug Manufacturing Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Biological API Drug Manufacturing Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Biological API Drug Manufacturing Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Biological API Drug Manufacturing Sales and Growth Rate (2014-2019)

    10 Global Biological API Drug Manufacturing Market Segment by Type

    • 10.1 Global Biological API Drug Manufacturing Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Biological API Drug Manufacturing Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Biological API Drug Manufacturing Revenue and Market Share by Type (2014-2019)
    • 10.2 In-House manufacturing Sales Growth and Price
      • 10.2.1 Global In-House manufacturing Sales Growth (2014-2019)
      • 10.2.2 Global In-House manufacturing Price (2014-2019)
    • 10.3 Contract manufacturing Sales Growth and Price
      • 10.3.1 Global Contract manufacturing Sales Growth (2014-2019)
      • 10.3.2 Global Contract manufacturing Price (2014-2019)

    11 Global Biological API Drug Manufacturing Market Segment by Application

    • 11.1 Global Biological API Drug Manufacturing Sales Market Share by Application (2014-2019)
    • 11.2 Monoclonal Antibody (mAb) Therapies Sales Growth (2014-2019)
    • 11.3 Vaccines Sales Growth (2014-2019)
    • 11.4 Insulin Therapies Sales Growth (2014-2019)
    • 11.5 Interferon Therapies Sales Growth (2014-2019)
    • 11.6 Other Sales Growth (2014-2019)

    12 Biological API Drug Manufacturing Market Forecast (2019-2024)

    • 12.1 Global Biological API Drug Manufacturing Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Biological API Drug Manufacturing Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Biological API Drug Manufacturing Market Forecast (2019-2024)
      • 12.2.2 Europe Biological API Drug Manufacturing Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Biological API Drug Manufacturing Market Forecast (2019-2024)
      • 12.2.4 South America Biological API Drug Manufacturing Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Biological API Drug Manufacturing Market Forecast (2019-2024)
    • 12.3 Biological API Drug Manufacturing Market Forecast by Type (2019-2024)
      • 12.3.1 Global Biological API Drug Manufacturing Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Biological API Drug Manufacturing Market Share Forecast by Type (2019-2024)
    • 12.4 Biological API Drug Manufacturing Market Forecast by Application (2019-2024)
      • 12.4.1 Global Biological API Drug Manufacturing Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Biological API Drug Manufacturing Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Description

      Scope of the Report:
      The worldwide market for Biological API Drug Manufacturing is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Biological API Drug Manufacturing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Lonza
      AbbVie
      DSM
      Boehringer Ingelheim BioXcellence
      Cytovance Biologics
      Celltrion
      CEPiA Sanofi
      Fujifilm Diosynth Biotechnologies
      Samsung BioLogics
      Baxter
      Wuxi Biologics
      GSK
      Vetter
      Pfizer CentreOne
      Sandoz

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      In-House manufacturing
      Contract manufacturing

      API contract manufacturing dominates the global biological API drug manufacturing market.

      Market Segment by Applications, can be divided into
      Monoclonal Antibody (mAb) Therapies
      Vaccines
      Insulin Therapies
      Interferon Therapies
      Other

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Biological API Drug Manufacturing product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Biological API Drug Manufacturing, with price, sales, revenue and global market share of Biological API Drug Manufacturing in 2017 and 2018.
      Chapter 3, the Biological API Drug Manufacturing competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Biological API Drug Manufacturing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Biological API Drug Manufacturing market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Biological API Drug Manufacturing sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now